Cargando…
Changing FDA Approval Standards: Ethical Implications for Patient Consent
Autores principales: | Darrow, Jonathan J., Dhruva, Sanket S., Redberg, Rita F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029608/ https://www.ncbi.nlm.nih.gov/pubmed/33834346 http://dx.doi.org/10.1007/s11606-021-06762-0 |
Ejemplares similares
-
Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports
por: Chang, Lee, et al.
Publicado: (2015) -
Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018) -
Medical Device Regulation: Time to Improve Performance
por: Dhruva, Sanket S., et al.
Publicado: (2012) -
Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development
por: Brockmann, Rouen, et al.
Publicado: (2023) -
Consent Codes: Upholding Standard Data Use Conditions
por: Dyke, Stephanie O. M., et al.
Publicado: (2016)